Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients

Paula Rı́o(Centre for Biomedical Network Research on Rare Diseases), Juan A. Bueren(Centro de Investigación Biomédica en Red), Sabine Charrier(Inserm), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), José C. Segovia(Unidades Centrales Científico-Técnicas), Julián Sevilla(University of Southern Denmark), Rebeca Sánchez‐Domínguez, Rosa María Pérez Yáñez(Instituto de Salud Carlos III), José Antonio Casado(Centre for Biomedical Network Research on Rare Diseases), Jordi Surrallés(Universitat Autònoma de Barcelona), María Roser Pujol(Universitat Autònoma de Barcelona), Parinda A. Mehta(Cincinnati Children's Hospital Medical Center), Guillermo Güenechea(Centre for Biomedical Network Research on Rare Diseases), María L. Lamana(Centre for Biomedical Network Research on Rare Diseases), Anne Galy(Centre National de la Recherche Scientifique)
Blood
August 11, 2017
Cited by 60


Related Papers